Oxford Metrics' Vicon team up with Red Bull Diagnostics and Training Centre
Francesca Morgan
Company News - 2 mins
09:28, 7th November 2019

International software firm, Oxford Metrics (OMG) FOLLOW, announced on Thursday that its motion capture business, Vicon, had signed a contract with Red Bull Diagnostics and Training Centre to utilise its inertial tracking solution.

As an existing customer, Red Bull has chosen to invest in Vicon’s tracking solution to help reduce the risk of injury as well as optimise the performance of athletes. 

The widening partnership also involves the Austrian-based Diagnostics and Training Centre, a centre which rehabilitates and trains Red Bull athletes in sport disciplines ranging from athletics to triathlon. 

For over four years, Red Bull’s athletes have greatly benefited by using Vicon’s optical system, the company explained.

Under the new deal, Red Bull will use a combination of Blue Trident inertial sensors and the IMU Step app with the former offering immediate analysis in the field or water, and the latter monitoring lower limb load during training.

“Now, with the addition of Vicon inertial tracking, we can obtain precise diagnostic metrics relating to asymmetry and limb loading during training to better manage injury risk and maximize the performance of our athletes,” said Christian Maurer-Grubinger of Red Bull Diagnostics and Training Centre.

Commenting on the deal, Chief Executive of Oxford Metrics, Nick Bolton stated, “Through Vicon's unique combination of optical and inertial solutions, Red Bull will better track, analyse and optimise their athletes' performance.

We are proud Red Bull Diagnostics and Training Centre have chosen Vicon as an integral part of their training programmes and we look forward to watching their athletes compete around the world."

Follow News & Updates from Oxford Metrics here: FOLLOW

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Comments
info
Login or register to post comments

Recent Articles
Watchlist